Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 8/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.41 |
| ▸ | SCD | O00767 | 1/20 | 0.37 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.36 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | CLPP | Q16740 | 1/20 | 0.33 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4013561 | 0.81 | ADORA2B (0.42) | ADORA2BADORA1ADORA2AADORA3 | |
| SCHEMBL5685358 | 0.78 | ADORA2B (0.45) | ADORA2BADORA1ADORA2AADORA3 | |
| SCHEMBL5685510 | 0.76 | ADORA2B (0.49) | ADORA2BADORA1ADORA2ASCDADORA3 | |
| SCHEMBL5608377 | 0.73 | ADORA2B (0.50) | ADORA2BADORA1ADORA2AADORA3 | |
| SCHEMBL1720832 | 0.69 | ADORA2B (0.37) | ADORA2BDAO | |
| SCHEMBL2822621 | 0.66 | ALK (0.45) | ADORA2BADORA1ADORA2ASCDKLKB1 | |
| SCHEMBL1065674 | 0.66 | ADORA2B (0.62) | ADORA2BADORA1ADORA2AADORA3 | |
| SCHEMBL15642930 | 0.65 | HCAR2 (0.43) | ADORA2BADORA1ADORA2AADORA3HDAC1 | |
| Hydrochloric Acid SCHEMBL21492821 | 0.65 | MAPT (0.48) | ADORA2BADORA1ADORA2ASCDKLKB1 | |
| SCHEMBL30012217 | 0.64 | ADORA2B (0.71) | ADORA2BADORA1ADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009088518-A1 | A2B ADENOSINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER | CV THERAPEUTICS, INC. (US) | 2009-07-16 | — | — | WO | disclosed |
| EP-1622908-A1 | XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS, INC. (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004106337-A1 | XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS, INC. (US) | 2004-12-09 | — | — | WO | disclosed |